Association between Helicobacter pylori infection and the subsequent risk of end-stage renal disease: A nationwide population-based cohort study

International Journal of Clinical Practice

Volumn 69, Issue 5, 2015, Pages 604-610

  Lin, S Y ^a,b   Lin, C L ^a,b   Liu, J H ^b   Yang, Y F ^b   Huang, C C ^a,b   Kao, C H ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HELICOBACTER INFECTION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; COMPLICATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOSPITALIZATION; KIDNEY FAILURE, CHRONIC; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84928588803     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12602     Document Type: Article

References (42)

1. Parkin DM,. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-44.
2. Schlemper RJ, van der Werf SD, Biemond I, Lamers CB,. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastro Hepatol 1996; 8: 33-9.
3. Rauws E, Tytgat G,. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
5. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 1591-4.
6. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcera randomized, controlled study. Ann Intern Med 1992; 116: 705-8.
7. Wotherspoon A, Diss T, Pan L, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
8. Wong BC-Y, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA 2004; 291: 187-94.
9. Franceschi F, Zuccala G, Roccarina D, Gasbarrini A,. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2014; 11: 234-42.
10. Niccoli G, Franceschi F, Cosentino N, et al. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 2010; 21: 217-21.
11. Shih HY, Kuo FC, Wang SS, et al. Helicobacter pylori infection and anemia in Taiwanese adults. Gastroenterol Res Pract 2013; 2013: 390967.
12. Shousha S, Arnaout AH, Abbas SH, Parkins RA,. Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol 1990; 43: 397-9.
13. Jaspersen D, Fassbinder W, Heinkele P, et al. Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol 1995; 30: 585-8.
14. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y,. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96-103.
15. Cheng CL, Kao YHY, Lin SJ, Lee CH, Lai ML,. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-42.
16. Yu Y-B, Gau J-P, Liu C-Y, et al. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost 2012; 108: 225.
17. Huang W-S, Yang T-Y, Shen W-C, Lin C-L, Lin M-C, Kao C-H,. Association between Helicobacter pylori infection and dementia. J Clin Neurosci 2014; 21: 1355-8.
18. Lin S-Y, Liu J-H, Yeh H-C, et al. Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis 2014; 000: 1-7.
19. Hsu W-Y, Lin C-H, Lin C-C, Sung F-C, Hsu C-P, Kao C-H,. The relationship between Helicobacter pylori and cancer risk. Eur J Intern Med 2014; 25: 235-40.
20. Lai C-Y, Yang T-Y, Lin C-L, Kao C-H,. Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 2014 Jul 26. [Epub ahead of print].
21. Huang W-S, Tseng C-H, Lin C-L, Tsai C-H, Kao C-H,. Helicobacter pylori infection increases subsequent ischemic stroke risk: a nationwide population-based retrospective cohort study. QJM 2014; 107: 969-75.
22. Yu T-M, Lin C-L, Chang S-N, Sung F-C, Kao C-H,. Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia. Neurology 2014; 83: 686-94.
23. Huang S-T, Lin C-L, Chang Y-J, et al. Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients. Kidney Int 2014; 86: 1023-30.
24. Lin S-Y, Lin W-M, Lin C-L, et al. The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: a population based cohort study. Eur J Intern Med 2014; 25: 276-80.
25. Lee C-F, Lin C-L, Lin M-C, Lin S-Y, Sung F-C, Kao C-H,. Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study. J Periodontol 2014; 85: 50-6.
26. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-9.
27. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D,. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007; 121: 229-38.
28. Lip G, Wise R, Beevers G,. Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ 1996; 312: 250.
29. Satoh H, Saijo Y, Yoshioka E, Tsutsui H,. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb 2010; 17: 1041.
30. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219-22.
31. Keane WF, Kasiske BL, O'Donnell MP,. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 1988; 8: 261-71.
32. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G,. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005; 68: 237-45.
33. Afsar B, Ozdemir FN, Elsurer R, Sezer S,. Helicobacter pylori infection may increase renal resistive index. Med Hypotheses 2007; 69: 956-7.
34. Kuipers E, Pena A, Festen H, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8.
35. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43.
36. Sipponen P, Laxen F, Huotari K, Härkönen M,. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003; 38: 1209-16.
37. Marra M, Bonfigli AR, Bonazzi P, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter 2005; 10: 609-14.
38. Mihout F, Shweke N, Bige N, et al. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis. J Pathol 2011; 223: 37-45.
39. Zoccali C,. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33.
40. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J,. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003; 14: 2934-41.
41. Cusick M, Chew EY, Hoogwerf B, et al. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int 2004; 66: 1173-9.
42. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401.